Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Fertility preservation options for women with malignancies
Enbal Marhhom,
Ilan Cohen
*
*
Corresponding author for this work
Meir Hospital Sapir Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
102
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fertility preservation options for women with malignancies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Young Women
100%
Chemotherapy
100%
Young Age
100%
Increased Demand
100%
Malignancy
100%
Cancer Types
100%
Fertility Preservation
100%
Loss of Ovarian Function
100%
Fertility Preservation Treatment
100%
Early Loss
100%
Seeking Help
50%
Menopause
50%
In Cancer
50%
Childbearing
50%
Number of Options
50%
Survival Rate
50%
Cancer Treatment
50%
Radiotherapy
50%
Patients at Risk
50%
Very Young
50%
Family Physicians
50%
Oocyte Cryopreservation
50%
Associated Complications
50%
Cytotoxic Therapy
50%
Common Cancers
50%
Embryo Cryopreservation
50%
Preserve Fertility
50%
Reproductive Organs
50%
Obstetrician-gynecologists
50%
Reproductive Function
50%
Premature Ovarian Failure
50%
Western Hemisphere
50%
Partner Status
50%
Medicine and Dentistry
Malignant Neoplasm
100%
Fertility Preservation
100%
Cancer
100%
Ovary Function
66%
Hemisphere
33%
Survival Rate
33%
Cancer Types
33%
Cancer Therapy
33%
Embryo Cryopreservation
33%
Reproductive Organ
33%
Primary Ovarian Insufficiency
33%
Cryopreservation
33%
Reproductive Medicine
33%
Radiation Therapy
33%